AVEO Pharmaceuticals, Inc. (AVEO)

[Biotech Pharmer]

They've already met with the FDA and agreed that AVEO would submit the NDA in Q1 followed by the final hazard ratio readout of T3 data in June, with a <1 reading being the hinge pin on that readout as to whether the NDA moves forward or is withdrawn. It's very peculiar how some here lie on every post they make.